Experimental pain med could give patients new option to opioids
The first new kind of pain medication in over two decades could be on the horizon for patients, with promising results announced Tuesday from a company trial.
Jan 30, 2024
0
0
The first new kind of pain medication in over two decades could be on the horizon for patients, with promising results announced Tuesday from a company trial.
Jan 30, 2024
0
0
Britain's medicines regulator has authorized the world's first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K.
Nov 16, 2023
0
1
Researchers from Skoltech, the University of Arizona and Linköping University in Sweden have created a graphical model that describes the patterns of infection outbreaks spreading between different localities. The model ...
Aug 15, 2022
0
120
Officials from Vertex Pharmaceuticals and CRISPR Therapeutics have announced that preliminary results from testing CRISPR gene-editing treatment in human patients with blood disorders show promise thus far. The joint project ...
Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will ...
Jul 2, 2015
0
9
As new treatments for hepatitis C virus (HCV) are approved, biomedical scientists are exploring their mechanisms and what they reveal about the virus. An online publication this month in Hepatology is the first to report ...
May 28, 2014
0
0
Male pattern baldness is linked to an increased risk of coronary heart disease, but only if it's on the top/crown of the head, rather than at the front, finds an analysis of published evidence in the online journal BMJ Open.
Apr 3, 2013
0
0
The first drug that treats the root cause of cystic fibrosis won approval Tuesday, offering a life-changing treatment for a handful of patients with the deadly illness and broader hope for thousands more patients with the ...
Jan 31, 2012
0
0
A new study has confirmed that the drug, ivacaftor (VX-770), significantly improves lung function in some people with cystic fibrosis (CF). The results of the phase III clinical trial study, "A CFTR Potentiator in Patients ...
Nov 2, 2011
0
0